Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Operating Expenses (2016 - 2025)

Conmed's Operating Expenses history spans 16 years, with the latest figure at $181.7 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 24.56% year-over-year to $181.7 million; the TTM value through Dec 2025 reached $647.9 million, up 21.62%, while the annual FY2025 figure was $647.9 million, 21.62% up from the prior year.
  • Operating Expenses reached $181.7 million in Q4 2025 per CNMD's latest filing, up from $154.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $181.7 million in Q4 2025 to a low of $108.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $134.8 million, with a median of $134.8 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: dropped 17.76% in 2024, then soared 36.15% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $118.6 million in 2021, then increased by 12.07% to $133.0 million in 2022, then fell by 0.73% to $132.0 million in 2023, then increased by 10.5% to $145.8 million in 2024, then increased by 24.56% to $181.7 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Operating Expenses are $181.7 million (Q4 2025), $154.2 million (Q3 2025), and $150.2 million (Q2 2025).